Skip to content

Company information lookup

CYNATA THERAPEUTICS LIMITED (CYP)

Stem cell and regenerative medicine development.

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
CYP 0.330 3.12% 0.340 0.345 0.345 0.345 0.330 52,360
(Status - RE)

CYNATA THERAPEUTICS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code CYP
Securities
Official Listing Date 20 December, 2007
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.ecoquest.com.au
Registered Office Address Suite 1, 1233 High Street, ARMADALE, VIC, AUSTRALIA, 3143
Head Office Telephone (03) 9824 5254
Head Office Fax (03) 9822 7735
Share Registry SECURITY TRANSFER REGISTRARS PTY. LIMITED
770 CANNING HIGHWAY, APPLECROSS, WA, AUSTRALIA, 6153
Share Registry Telephone (08) 9315 2333
Directors / Senior Management
Dr Stewart Washer (Executive Chairman)
Dr Ross Macdonald (Managing Director, CEO)
Mr Howard Digby (Non Exec. Director)
Mr Peter Webse (Non Exec. Director)
Company Secretary Mr Peter Webse
Principal Activities Stem cell and regenerative medicine development.

CYNATA THERAPEUTICS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
05/03/2014 asterix Cynata GvHD Partnership with University of Massachusetts 2 PDF
04/03/2014   Appendix 3Y - Stewart Washer 2 PDF
28/02/2014   Mr Howard Digby to Revert to Non-Executive Director Role 1 PDF
25/02/2014 asterix Appendix 4D & Half-Year Financial Statements 25 PDF
12/02/2014   Investor Presentation 22 PDF
10/02/2014 asterix Cynata Partners with Leading Biologic Product Manufacturer 1 PDF
30/01/2014 asterix Appendix 4C - quarterly 5 PDF
21/01/2014   Section 708A Notice 1 PDF
21/01/2014   Appendix 3B - Exercise of Listed Options 12 PDF
16/01/2014   Experienced Stem Cell Product Developer to Join Cynata 1 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
17 Apr 2014 0.330 3.12% 0.345 0.330 52,360
16 Apr 2014 0.320 0% 0.320 0.320 5,000
15 Apr 2014 0.320 -11.11% 0.320 0.320 4,498
11 Apr 2014 0.360 -5.26% 0.360 0.350 33,730
10 Apr 2014 0.380 -2.56% 0.390 0.380 24,334

* Volume of shares shown represents only those shares traded on ASX.

CYNATA THERAPEUTICS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security CYP. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security CYP

Warrants & Structured Products

No warrants & Structured Products are available over the security CYP

ASX CFDs

No Contracts For Differences are available over the security CYP